AR061663A1 - Procesos para la preparacion de inhibidores de iv dpp. composiciones farmaceuticas y compuestos relacionados. - Google Patents
Procesos para la preparacion de inhibidores de iv dpp. composiciones farmaceuticas y compuestos relacionados.Info
- Publication number
- AR061663A1 AR061663A1 ARP070102855A ARP070102855A AR061663A1 AR 061663 A1 AR061663 A1 AR 061663A1 AR P070102855 A ARP070102855 A AR P070102855A AR P070102855 A ARP070102855 A AR P070102855A AR 061663 A1 AR061663 A1 AR 061663A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- unsubstituted
- preparation
- pharmaceutical compositions
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Sal farmacéuticamente aceptable del mismo, para el tratamiento de la diabetes Tipo 2.Composiciones farmacéuticas que lo contienen Reivindicacion 1: Un proceso para la preparacion de un compuesto de la formula 1, y esteroisomeros de los mismos, en donde X es un cicloalquilo sustituido o no sustituido, cicloalquenilo sustituido o no sustituido, arilo sustituido o no sustituido, aralquilo sustituido o no sustituido, heteroarilo sustituido o no sustituido, anillo heterocíclico sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, o heteroarilalquilo sustituido o no sustituido, y R es alquilo C1-4, que comprende el paso de condensar el compuesto de la formula 2 con un éster de ácido glioxálico.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1009MU2006 | 2006-06-27 | ||
IN1008MU2006 | 2006-06-27 | ||
US80732706P | 2006-07-13 | 2006-07-13 | |
US83169706P | 2006-07-17 | 2006-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR061663A1 true AR061663A1 (es) | 2008-09-10 |
Family
ID=38626165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070102855A AR061663A1 (es) | 2006-06-27 | 2007-06-27 | Procesos para la preparacion de inhibidores de iv dpp. composiciones farmaceuticas y compuestos relacionados. |
Country Status (5)
Country | Link |
---|---|
US (1) | US7893103B2 (es) |
EP (1) | EP2035395A2 (es) |
AR (1) | AR061663A1 (es) |
TW (1) | TW200808770A (es) |
WO (1) | WO2008001195A2 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2008002427A1 (es) | 2007-08-16 | 2009-09-11 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2. |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
CN103816158A (zh) | 2008-08-15 | 2014-05-28 | 勃林格殷格翰国际有限公司 | 用于治疗fab-相关疾病的嘌呤衍生物 |
US8404727B2 (en) | 2009-01-07 | 2013-03-26 | Glenmark Pharmaceuticals S.A. | Pharmaceutical composition that includes a dipeptidyl peptidase-IV inhibitor |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
PL2376447T3 (pl) * | 2009-01-09 | 2018-04-30 | Orchid Pharma Limited | Inhibitory dipeptydylopeptydazy iv |
TWI466672B (zh) | 2009-01-29 | 2015-01-01 | Boehringer Ingelheim Int | 小兒科病人糖尿病之治療 |
BRPI1013639A2 (pt) | 2009-02-13 | 2016-04-19 | Boehringer Ingelheim Int | medicamentos antidiabéticos |
SI2395983T1 (sl) | 2009-02-13 | 2020-08-31 | Boehringer Ingelheim International Gmbh | Farmacevtski sestavek, ki obsega SGLT2 inhibitor, DPP-IV inhibitor in po izbiri nadaljnje antidiabetično sredstvo in uporabe le-teh |
US9457029B2 (en) | 2009-11-27 | 2016-10-04 | Boehringer Ingelheim International Gmbh | Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
US20130109703A1 (en) | 2010-03-18 | 2013-05-02 | Boehringer Ingelheim International Gmbh | Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions |
BR112012028136A2 (pt) | 2010-05-05 | 2016-08-09 | Boehringer Ingelheim Int | terapia de combinaçao |
KR20130093012A (ko) | 2010-06-24 | 2013-08-21 | 베링거 인겔하임 인터내셔날 게엠베하 | 당뇨병 요법 |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
AR120680A1 (es) | 2019-12-06 | 2022-03-09 | Vertex Pharma | Tetrahidrofuranos sustituidos como moduladores de canales de sodio |
TW202322824A (zh) | 2020-02-18 | 2023-06-16 | 美商基利科學股份有限公司 | 抗病毒化合物 |
CA3216162A1 (en) | 2021-04-16 | 2022-10-20 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
WO2022256622A1 (en) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR7639M (es) | 1967-09-14 | 1970-02-02 | ||
ATE370943T1 (de) * | 2001-06-27 | 2007-09-15 | Smithkline Beecham Corp | Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren |
AU2002360732A1 (en) * | 2001-12-26 | 2003-07-24 | Guilford Pharmaceuticals | Change inhibitors of dipeptidyl peptidase iv |
JPWO2004050654A1 (ja) * | 2002-11-29 | 2006-03-30 | 塩野義製薬株式会社 | ピロリジン化合物の合成とその塩 |
AU2003902260A0 (en) * | 2003-05-09 | 2003-05-29 | Fujisawa Pharmaceutical Co., Ltd. | Dpp-iv inhibitor |
KR20060037417A (ko) * | 2003-08-18 | 2006-05-03 | 다이쇼 세이야꾸 가부시끼가이샤 | cis-4-플루오로-L-프롤린 유도체의 제조법 |
WO2005075426A1 (en) * | 2004-02-03 | 2005-08-18 | Glenmark Pharmaceuticals Ltd. | Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
WO2006011035A1 (en) * | 2004-07-23 | 2006-02-02 | Glenmark Pharmaceuticals Ltd. | Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
WO2006040625A1 (en) | 2004-10-12 | 2006-04-20 | Glenmark Pharmaceuticals S.A. | Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
-
2007
- 2007-06-26 EP EP07766586A patent/EP2035395A2/en not_active Withdrawn
- 2007-06-26 WO PCT/IB2007/001743 patent/WO2008001195A2/en active Application Filing
- 2007-06-27 AR ARP070102855A patent/AR061663A1/es unknown
- 2007-06-27 US US11/769,180 patent/US7893103B2/en not_active Expired - Fee Related
- 2007-06-27 TW TW096123265A patent/TW200808770A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2035395A2 (en) | 2009-03-18 |
TW200808770A (en) | 2008-02-16 |
US7893103B2 (en) | 2011-02-22 |
WO2008001195A2 (en) | 2008-01-03 |
US20080076818A1 (en) | 2008-03-27 |
WO2008001195A3 (en) | 2008-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR061663A1 (es) | Procesos para la preparacion de inhibidores de iv dpp. composiciones farmaceuticas y compuestos relacionados. | |
EA200970510A1 (ru) | Гетеромоноциклическое соединение и его применение | |
AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
AR053415A1 (es) | Inhibidores dipeptidil peptidasa iv, composiciones farmaceuticas que los contienen y procesos para la preparacion de los compuestos y de la composicion | |
AR091857A1 (es) | INHIBIDORES DE CISTATIONIN-g-LIASA (CSE) | |
AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
RS53389B (en) | PHARMACEUTICAL UNITS | |
EA014959B3 (ru) | Ингибиторы глицинового переносчика-1 | |
TNSN07395A1 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
EA200900481A1 (ru) | Новые соединения индола, способ их получения и фармацевтические композиции, которые их содержат | |
EA200900480A1 (ru) | Новые соединения индола, способ их получения и фармацевтические композиции, которые их содержат | |
WO2009021957A3 (en) | Tricyclic heterocyclic compounds as gaba a modulators | |
EA201000832A1 (ru) | Замещённые 3-гидроксипиридины и содержащие их фармацевтические композиции | |
EA201000867A1 (ru) | Новые соединения 2-меркаптоциклопентанкарбоновой кислоты, способ их получения и содержащие их фармацевтические композиции | |
BRPI0607087A2 (pt) | derivados de oximas heterocìclicos, o respectivo processo de preparo e as composições farmacêuticas que os contêm | |
SE0400440D0 (sv) | Novel Cinnamic Amides | |
TH83713B (th) | อนุพันธ์ 2-(ไซคลิกอะมิโนคาร์บอนิล)อินโดลีน และ ส่วนผสมทางเภสัชกรรมที่มีสารนี้อยู่ | |
AR123784A1 (es) | Derivados de tetrazol como inhibidores de trpa1 | |
TH83713A (th) | อนุพันธ์ 2-(ไซคลิกอะมิโนคาร์บอนิล)อินโดลีนและส่วนผสมทางเภสัชกรรมที่มีสารนี้อยู่ | |
TH96085A (th) | พิริดีน แอนาลอก iii 334 ชนิดใหม่ | |
TH96576A (th) | อนุพันธ์ของกรดฟีนิลอะซิติก ในฐานะเป็นสารยับยั้ง cox-2 | |
TH94332A (th) | ตัวยับยั้งแกมมาซีครีเตสกลุ่มไตรไซคลิกซัลโฟนาไมด์ชนิดวงแหวนเชื่อมติด | |
TH95760A (th) | สารประกอบตัวใหม่ | |
TH135149B (th) | สารรักษาโรคหรือป้องกันโรคสำหรับโรคทางเดินน้ำดี | |
TH108872A (th) | อนุพันธ์ของออกโซไพราซีน และสารฆ่าวัชพืช |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |